Suppr超能文献

青少年椎间盘突出症。木瓜凝乳蛋白酶治疗的长期随访。

Adolescent disc protrusions. A long term follow-up of chymopapain therapy.

机构信息

Harlow Wood Orthopaedic Hospital, Mansfield, Nottingham, UK.

出版信息

Eur Spine J. 1992 Dec;1(3):156-62. doi: 10.1007/BF00301306.

Abstract

The management of adolescent disc protrusions by chemonucleolysis has received little attention in the literature, and reports of the long-term outcome are lacking. Between May 1978 and July 1986 42 patients between the ages of 13 and 19 years with radiologically proven lumbar disc protrusions were treated at this institution with chymopapain. They were followed prospectively for 1 year, and the procedure was successful in 27 patients (64%). Of the 15 patients in whom the treatment failed, 11 underwent subsequent surgical discectomy, successful in 10, giving an overall treatment success rate of 37/42 (88%) at 1 year. The patients were contacted by telephone and questionnaire at a minimum of 5 years after treatment (mean 8.5 years), and full replies were obtained from 39/42 (93%). The long-term outcome was good or excellent in 82%. A history of injury, and the demonstration by MRI or discography of disc degeneration at more than one level was associated with a reduced success rate both at 1 year and in the long term. We conclude that there are no long-term ill effects of chemonucleolysis with chymopapain on the adolescent disc. It is a useful procedure that is well tolerated and we have no reservations about its use.

摘要

青少年椎间盘突出症的化学核溶解治疗在文献中很少受到关注,缺乏长期结果的报道。1978 年 5 月至 1986 年 7 月,本机构对 42 例年龄在 13 至 19 岁之间、经放射学证实的腰椎间盘突出症患者采用木瓜凝乳蛋白酶进行治疗。他们进行了为期 1 年的前瞻性随访,27 例(64%)患者的治疗成功。在治疗失败的 15 例患者中,11 例随后接受了手术椎间盘切除术,其中 10 例成功,1 年时的总体治疗成功率为 37/42(88%)。在治疗后至少 5 年(平均 8.5 年)通过电话和问卷调查联系了患者,42 例中的 39 例(93%)做出了完整答复。长期结果为良好或优秀的比例为 82%。有外伤史,以及 MRI 或椎间盘造影术显示多个节段椎间盘退变,与 1 年时和长期时的成功率降低有关。我们的结论是,青少年椎间盘使用木瓜凝乳蛋白酶化学核溶解治疗没有长期不良影响。它是一种有用的治疗方法,患者耐受性良好,我们对其使用没有任何保留。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验